2020 ANNUAL REPORT

Performance

Performance

A regular performance over 30 years

The Group was fully mobilized to serve its customers and patients in 2020, which was an out of the ordinary year. The Group’s performance was outstanding in this environment: sales resilience, significant margin improvement, net profit growth and investment decisions continued at a very high level. This performance illustrates the solidity of our business model.

EVOLUTION OF GROUP REVENUE

over 30 years (in millions of euros)

 

  • 1990: 4,408
  • 2000: 8,099
  • 2010: 13,488
  • 2020: 20,485

+5.3%

average annual growth(1)

EVOLUTION OF ADJUSTED NET EARNINGS(2) PER SHARE

over 30 years (in euros)

 

  • 1990: 0.74
  • 2000: 1.47
  • 2010: 3.29
  • 2020: 5.16

+6.7%

average annual growth(1)

EVOLUTION OF ADJUSTED DIVIDEND(2) PER SHARE

over 30 years (in euros)

  • 1990: 0.24
  • 2000: 0.61
  • 2010: 1.55
  • 2020: 2.75

+8.5%

average annual growth(1)

2020 key financial figures

REVENUE

€20,485 M

NET PROFIT (Group share)

€2,435 M +1.5%(4)

OIR MARGIN

18.5% +80pbs(5)

EFFICIENCY GAINS

€441 M

GEARING

55.8%

INVESTMENT DECISIONS

€3.2 bn

2020 key extra-financial figures

SAFETY

0.9

Frequency rate of accidents with time off work per million hours worked. This is the lowest frequency rate of the last 20 years.

CARBON INTENSITY(6)

-30%

Reduction in carbon intensity over the past five years, in line with the target set for 2025

DIVERSITY

30%

of women among Engineers and Professionals